Cervical cancer is the second most common cancer globally among women between the ages of 20 and 55. It is caused by the human papillomavirus (HPV). Cervical cancer is the final stage of untreated HPV infection, characterized by the continuing presence of HPV and detected by repeated DNA testing of cervical samples. HPV infection is primarily sexually transmitted and usually occurs without clinical signs or symptoms.

The process from HPV infection to cancer is slow. This makes the initiating infections and the pre-disease lesions treatable with regular prophylaxis, thus preventing the development of cervical cancer.

Primary Screening for Cervical Cancer


Until a few years ago the only diagnostic approach to preventing cervical cancer was cytological screening. The cytosmear (PAP test) is a medical test for the prevention of cervical cancer and is currently used in parallel with the HPV DNA test for cervical cancer screening.

The discovery of HPV as a cause of cervical cancer has led to important technological advances, including the development of molecular genetic tests for HPV to identify women who are virus carriers and / or exhibit HPV-associated oncogenic activity. The HPV DNA test aims to detect types of HPV associated with a high risk of developing cervical cancer. Detection of the virus is possible at a very early stage of infection and long before the detection of HPV-initiated atypical cytological changes in the cytosmear. This makes the HPV DNA test the only early prognostic marker of cervical cancer. At the same time, it helps to determine the therapeutic approach.


Up to 93% of cervical cancers are preventable with GENICA’s diagnostic solutions

The ThinPrep® PAP test is significantly more accurate than a regular smear

Care for Your Loved ones
Anyone can be an HPV carrier without having any symptoms

Combined screening with the ThinPrep® PAP test + HPV test provides the best possible annual cervical cancer prophylaxis

Prevention and Control of HPV Infections
Every women - HPV carrier is at risk of developing cervical cancer
HPV infections are very common

HPV infections are so common that almost every man and woman will become infected with at least one type of HPV at some point in their lives.

Some HPV infections can cause cancer

Most HPV infections (9 out of 10) go away on their own within two years. Sometimes HPV infections last longer and can cause some types of cancers. HPV infections can cause cancer of: the cervix, vagina, vulva, penis, anus and throat.

Regular prophylactic tests will protect you from cancer

An integrated approach through HPV DNA testing and liquid-based cytology (a new generation of smears) is key to success in the fight against cervical cancer. 

To limit the rapid development of cervical cancer, testing for other sexually transmitted infections is recommended when a positive HPV test is registered.

Prevent cancer with HPV vaccine

Centers for Disease Control and Prevention (CDC) recommends that all boys and girls be vaccinated against HPV between the ages of 11 and 12. This age recommendation ensures that children will be protected long before they are exposed to the virus due to sexual activity.


HPV vaccine does not provide complete protection. It covers only certain types of HPV and has no 100% protective effect. Regular screening is the only safe way to avoid developing HPV-induced cancer.

Download Our Brochures

Latest Laboratory Practices
Patient Care

Providing up-to-date information, medical research and scientific data to help people lead safer and healthier life by preventing HPV infections and the complications they cause is the mission of the HPV Diagnostics Department at GENIKA.

The specific objectives of the department are the promotion of sexual health and the primary prevention of sexually transmitted diseases.

Nucleic acid amplification tests (NAAT; PCR) are the only diagnostic option for detecting HPV. Our lab holds an international certificate for HPV diagnosis issued by Instand E.v. GENICA follows the recommendations of the World Health Organization (WHO) and offers all the latest test options for diagnosing HPV.

See Our Tests